TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2010
State/Territory | Current | Active | ||||||
---|---|---|---|---|---|---|---|---|
Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
Alabama | 302 | 27.8 | 3.8 | (20.4 – 35.2) | 317 | 25.3 | 3.5 | (18.4 – 32.2) |
Arizona | 273 | 31.7 | 6.2 | (19.5 – 43.9) | 283 | 31.0 | 6.1 | (19.0 – 43.0) |
California | 502 | 36.3 | 2.9 | (30.6 – 42.0) | 545 | 33.6 | 2.8 | (28.1 – 39.1) |
Connecticut | 250 | 37.0 | 4.9 | (27.4 – 46.6) | 283 | 34.5 | 4.4 | (25.9 – 43.1) |
District of Columbia | 134 | 43.5 | 5.9 | (31.9 – 55.1) | 151 | 39.8 | 5.5 | (29.0 – 50.6) |
Florida | 414 | 36.3 | 4.6 | (27.3 – 45.3) | 449 | 33.5 | 4.4 | (24.9 – 42.1) |
Georgia | 171 | 27.4 | 4.5 | (18.6 – 36.2) | 176 | 29.0 | 4.6 | (20.0 – 38.0) |
Hawaii | 271 | 41.4 | 4.9 | (31.8 – 51.0) | 287 | 42.8 | 4.7 | (33.6 – 52.0) |
Illinois | 166 | 36.1 | 5.2 | (25.9 – 46.3) | 173 | 34.9 | 5.0 | (25.1 – 44.7) |
Indiana | 482 | 32.3 | 3.1 | (26.2 – 38.4) | 508 | 32.7 | 3.0 | (26.8 – 38.6) |
Iowa | 261 | 31.0 | 3.7 | (23.7 – 38.3) | 270 | 29.5 | 3.6 | (22.4 – 36.6) |
Kansas | 426 | 37.0 | 3.8 | (29.6 – 44.4) | 442 | 36.0 | 3.7 | (28.7 – 43.3) |
Louisiana | 187 | 20.1 | 4.0 | (12.3 – 27.9) | 203 | 22.2 | 4.0 | (14.4 – 30.0) |
Maine | 466 | 34.5 | 3.0 | (28.6 – 40.4) | 486 | 34.4 | 3.0 | (28.5 – 40.3) |
Maryland | 256 | 28.3 | 4.4 | (19.7 – 36.9) | 284 | 27.5 | 4.1 | (19.5 – 35.5) |
Massachusetts | 220 | 32.1 | 5.0 | (22.3 – 41.9) | 231 | 33.6 | 5.0 | (23.8 – 43.4) |
Michigan | 540 | 36.1 | 3.0 | (30.2 – 42.0) | 573 | 35.0 | 2.9 | (29.3 – 40.7) |
Mississippi | 330 | 25.3 | 3.2 | (19.0 – 31.6) | 339 | 24.3 | 3.1 | (18.2 – 30.4) |
Missouri | 265 | 43.8 | 5.2 | (33.6 – 54.0) | 280 | 40.0 | 4.8 | (30.6 – 49.4) |
Montana | 326 | 27.9 | 3.8 | (20.5 – 35.3) | 339 | 26.4 | 3.6 | (19.3 – 33.5) |
Nebraska | 607 | 31.2 | 3.9 | (23.6 – 38.8) | 633 | 32.8 | 3.5 | (25.9 – 39.7) |
Nevada | 143 | 27.2 | 5.1 | (17.2 – 37.2) | 168 | 23.6 | 4.5 | (14.8 – 32.4) |
New Hampshire | 283 | 35.8 | 4.4 | (27.2 – 44.4) | 306 | 35.2 | 4.3 | (26.8 – 43.6) |
New Jersey | 346 | 30.9 | 3.9 | (23.3 – 38.5) | 377 | 28.7 | 3.5 | (21.8 – 35.6) |
New Mexico | 333 | 37.0 | 4.7 | (27.8 – 46.2) | 351 | 36.8 | 4.5 | (28.0 – 45.6) |
New York | 133 | 43.2 | 5.8 | (31.8 – 54.6) | 145 | 43.1 | 5.6 | (32.1 – 54.1) |
North Dakota | 178 | 38.5 | 6.1 | (26.5 – 50.5) | 185 | 38.5 | 5.9 | (26.9 – 50.1) |
Ohio | 357 | 31.9 | 4.2 | (23.7 – 40.1) | 382 | 30.2 | 4.0 | (22.4 – 38.0) |
Oklahoma | 343 | 35.2 | 4.1 | (27.2 – 43.2) | 365 | 33.5 | 3.9 | (25.9 – 41.1) |
Oregon | 208 | 36.5 | 5.3 | (26.1 – 46.9) | 234 | 32.7 | 4.7 | (23.5 – 41.9) |
Pennsylvania | 412 | 38.4 | 3.4 | (31.7 – 45.1) | 437 | 38.7 | 3.3 | (32.2 – 45.2) |
Rhode Island | 326 | 34.9 | 3.8 | (27.5 – 42.3) | 349 | 34.1 | 3.7 | (26.8 – 41.4) |
Texas | 651 | 37.5 | 4.7 | (28.3 – 46.7) | 721 | 35.1 | 4.5 | (26.3 – 43.9) |
Utah | 438 | 32.2 | 4.3 | (23.8 – 40.6) | 460 | 34.1 | 4.0 | (26.3 – 41.9) |
Vermont | 403 | 36.9 | 3.4 | (30.2 – 43.6) | 435 | 34.2 | 3.2 | (27.9 – 40.5) |
Washington | 676 | 32.1 | 3.0 | (26.2 – 38.0) | 706 | 32.4 | 2.8 | (26.9 – 37.9) |
West Virginia | 205 | 29.8 | 4.1 | (21.8 – 37.8) | 203 | 30.8 | 4.2 | (22.6 – 39.0) |
Wisconsin | 221 | 44.8 | 6.1 | (32.8 – 56.8) | 243 | 40.8 | 5.4 | (30.2 – 51.4) |
Puerto Rico | 118 | N/A | N/A | (N/A – N/A) | 159 | 24.9 | 7.3 | (10.6 – 39.2) |
39 state total | 12,623 | 35.4 | 1.0 | (33.4 – 37.4) | 13,478 | 34.0 | 1.0 | (32.0 – 36.0) |
Median | 35.1 | 33.6 | ||||||
Range | 20.1-44.8 | 22.2-43.1 |
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30